"The company suffered a setback last week when a Montgomery County Common Pleas Court judge rejected Inovio’s move to force its contract manufacturer to share proprietary technology with other suppliers.
Inovio argued that Houston-based VGXI is already at manufacturing capacity and is an obstacle to Inovio’s goal of being able to make one million doses of its vaccine by year’s end. Judge Jeffrey Saltz denied Inovio’s petition for a preliminary injunction, concluding that the claims are “too speculative.”"
News 
Market Data 
Discover 
AI
